Compare CTRE & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTRE | RGEN |
|---|---|---|
| Founded | 2013 | 1981 |
| Country | United States | United States |
| Employees | N/A | 2000 |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9B | 10.0B |
| IPO Year | 2013 | 1995 |
| Metric | CTRE | RGEN |
|---|---|---|
| Price | $37.21 | $194.54 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 12 |
| Target Price | $42.40 | ★ $167.67 |
| AVG Volume (30 Days) | ★ 1.6M | 910.6K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.44% | N/A |
| EPS Growth | 96.25 | ★ 286.96 |
| EPS | ★ 0.74 | 0.24 |
| Revenue | ★ $476,393,000.00 | $141,236,000.00 |
| Revenue This Year | $5.97 | $14.30 |
| Revenue Next Year | $13.39 | $14.52 |
| P/E Ratio | ★ $50.18 | $807.88 |
| Revenue Growth | ★ 60.79 | 35.10 |
| 52 Week Low | $32.79 | $100.99 |
| 52 Week High | $43.62 | $198.87 |
| Indicator | CTRE | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 33.44 | 70.11 |
| Support Level | $36.91 | $159.22 |
| Resistance Level | $41.66 | N/A |
| Average True Range (ATR) | 0.76 | 6.37 |
| MACD | -0.04 | 1.63 |
| Stochastic Oscillator | 10.16 | 86.80 |
CareTrust REIT Inc is a self-administered, publicly traded REIT engaged in the ownership, acquisition, financing, development, and leasing of skilled nursing, seniors housing, and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators under triple-net lease arrangements, in which the tenant is solely responsible for property-related costs. The company operates in Domestic and Foreign markets, with the majority of revenue coming from Domestic operations.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.